Flavonoid metabolites and susceptibility of rat lipoproteins to oxidation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 6 56-6, 2004, Pages

  Benito, Sonia ^a   Buxaderas, Susana ^a   Mitjavila, M Teresa ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antioxidants; Atherosclerosis; Catechin; Quercetin; Wine

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; CATECHIN; FLAVONOID; GLUCURONIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; QUERCETIN; RETINOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BEVERAGE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIETARY INTAKE; EX VIVO STUDY; IN VITRO STUDY; MALE; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RED WINE; VEGETABLE;

ALPHA-TOCOPHEROL; ANIMAL FEED; ANIMALS; ARTERIOSCLEROSIS; CATECHIN; CHOLESTEROL, LDL; FLAVONOIDS; LIPOPROTEINS; MALE; OXIDATION-REDUCTION; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN A; WINE;

EID: 9344223377     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00471.2004     Document Type: Article

References (44)

1. Baba S, Osakabe N, Natsume M, Muto Y, Takizawa T, and Terao J. In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats. J Nutr 131: 2885-2891, 2001.
2. Bell JR, Donovan JL, Wong R, Waterhouse AL, German JB, Walzem RL, and Kasim-Karakas SE. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am J Clin Nutr 71: 103-108, 2000.
3. Benito S, Lopez D, Sáiz MP, Buxaderas S, Sánchez J, Puig-Parellada P, and Mitjavila MT. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 135: 910-916, 2002.
4. Bieri JG, Tolliver TJ, and Catignani GL. Simultaneous determination of α-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr 32: 2143-2149, 1979.
5. Boulton DW, Walle UK, and Walle T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J Pharm Pharmacol 50: 243-249, 1998.
6. 2+ ions: implications for their antioxidant properties. Biochem J 330: 1173-1178, 1998.
7. Caccetta RA, Croft KD, Beilin LJ, and Puddey I. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr 71: 67-74, 2000.
8. 2+ oxidizability: possible explanation by phenolic location. Eur J Clin Nutr 52: 682-690, 1997.
9. Castellari M, Arfelli G, Riponi C, and Amati A. Evolution of phenolic compounds in red winemaking as affected by must oxygenation. Am J Enol Vit 49: 91-94, 1998.
10. Cren-Olivé C, Teissier E, Duriez P, and Rolande C. Effect of catechin O-methylated metabolites and analogues on human LDL oxidation. Free Radic Biol Med 34: 850-855, 2003.
11. Crespy V, Morand C, Manach C, Besson C, Demigne C, and Remesy C. Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am J Physiol Gastrointest Liver Physiol 277: G120-G126, 1999.
12. Denicola A, Bathyany C, Lissi E, Freeman BA, Rubbo H, and Radi R. Diffusion of nitric oxide into low density lipoproteins. J Biol Chem 277: 932-936, 2002.
13. De Rijke YB, Demacker PN, Assen NA, Sloots LM, Katan MB, and Stalenhoef AF. Red wine consumption does not affect oxidizability of low density lipoproteins in volunteers. Am J Clin Nutr 63: 329-334, 1996.
14. De Walley CV, Rankin SM, Hoult JR, Jessup W, and Leake DS. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 39: 1743-1750, 1990.
15. Donovan JL, Bell JR, Kasim-Karakas S, German JB, Walzem RL, Hansen RJ, and Waterhouse AL. Catechin is present as metabolites in human plasma after consumption of red wine. J Nutr 129: 1662-1668, 1999.
16. Esterbauer H, Striegl G, Puhl H, and Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoproteins. Free Radic Res Commun 6: 67-75, 1989.
17. Frankel EN, Kanner J, German JB, Parks E, and Kinsella JE. Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet 341: 454-457, 1993.
18. Fuhrman B, Lavy A, and Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 61: 549-554, 1995.
19. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, Elis A, and Aviram M. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 17: 2744-2752, 1997.
20. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic B, Toshima H, Feskens E, Hollman P, and Katan M. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155: 381-386, 1995.
21. Hogg N and Kalyanaraman B. Nitric oxide and low-density lipoprotein oxidation. Free Radic Res 28: 593-600, 1998.
22. Lamuela-Raventos RM, Covas MI, Fito M, Marrugat J, and de la Torre-Boronat MC. Detection of dietary antioxidant phenolic compounds in human LDL. Clin Chem 45: 1870-1872, 1999.
23. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, and Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106: 1614-1617, 2002.
24. Manach C, Texier O, Morand C, Crespy V, Régérat F, Demigné C, and Rémésy C. Comparison of the bioavailability of quercetin and catechin in rats. Free Radic Biol Med 27: 1259-1266, 1999.
25. Moon J, Tsushida T, Nakahara K, and Terao J. Identification of quercetin 3-O-β-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radic Biol Med 30: 1274-1285, 2001.
26. Morand C, Crespy V, Manach C, Besson C, Demigne C, and Remesy C. Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol Regul Integr Comp Physiol 275: R212-R219, 1998.
27. Nigdikar SV, Williams NR, Griffin BA, and Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins in vivo. Am J Clin Nutr 68: 258-265, 1998.
28. Noteborn HP, Jansen E, Benito S, and Mengerlers MJ. Oral absorption of quercetin and sugar-conjugated derivatives in specific transport systems. Cancer Lett 114: 175-177, 1997.
29. Olthof MR, Hollman PC, Vree TB, and Katan MB. Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. Nutrition 130: 1200-1203, 2000.
30. Pal S, Ho N, Santos C, Dubois P, Mamo J, Croft K, and Allister E. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells. J Nutr 133: 700-706, 2003.
31. Pietta P, Simonetti P, Gardana C, Brusamolino A, Morazzoni P, and Bombardelli E. Relationship between rate and extent of catechin absorption and plasma antioxidant status. Biochem Mol Biol Int 46: 895-903, 1998.
32. Piskula MK and Terao J. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J Nutr 128: 1172-1178, 1998.
33. Renaud S and de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526, 1992.
34. Rice-Evans C, Leake D, Bruckdorfer KR, and Diplock AT. Practical approaches to low density lipoprotein oxidation: whys, wherefore and pitfalls. Free Radic Res 25: 285-311, 1996.
35. Rice-Evans CA, Miller NJ, and Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20: 933-956, 1996.
36. Rifici VA, Schneider SH, and Khachadurian AK. Lipoprotein oxidation mediated by J774 murine macrophages is inhibited by individual red wine polyphenols but not by ethanol. J Nutr 132: 2532-2537, 2002.
37. Stocker R and O'Hallaran R. Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall. Am J Clin Nutr 79: 123-130, 2004.
38. Van het Hof KH, Wiseman SA, Yang CS, and Tijburg LB. Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc Soc Exp Biol Med 220: 203-209, 1999.
39. Vinson JA, Teufel K, and Wu N. Red wine, dealcoholised red wine and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 156: 67-72, 2001.
40. Waddington E, Puddey IB, and Croft KD. Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation. Am J Clin Nutr 79: 54-61, 2004.
41. Walle T, Walle UK, and Halushka PV. Carbon dioxide is the major metabolite of quercetin in humans. J Nutr 131, 2648-2652, 2001.
42. Waterhouse AL, German JB, Walzem RL, Hansen RJ, and Kasim-Karakas SE. Is it time for a wine trial? Am J Clin Nutr 68: 220-221, 1998.
43. Yagi K. Assay for blood plasma or serum. Methods Enzymol 105: 328-331, 1984.
44. Yamamoto N, Moon JH, Tsushida T, Nagao A, and Terao J. Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Arch Biochem Biophys 15: 347-354, 1999.